Merck KGaA and Remepy join forces to develop combo drug-digital therapies

April 28, 2026

More like this

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

Drug Discovery & Development

Hybridopa Shows Motor, Nonmotor Gains in Phase 2a Parkinson Disease Trial

Neurology Live

Remepy’s app-drug combo heads for Phase III on mid-stage Parkinson’s win

Clinical Trials Arena